Literature DB >> 18159397

Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia.

Tariq A Madani1.   

Abstract

OBJECTIVE: To describe the prevalence, demography and clinical characteristics of patients who were colonized or infected with methicillin-resistant Staphylococcus aureus (MRSA) in 1998 at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. PATIENTS AND METHODS: Results of MRSA-positive cultures of clinical specimens obtained as part of investigations for suspected infections were retrieved from the King Abdulaziz University Hospital Infection Control Department's records. Charts of patients were reviewed.
RESULTS: Of 292 S aureus isolates identified, 111 (38%) were MRSA, or 6.0 MRSA isolates/1000 admissions, which represented a marked increase over MRSA prevalence in 1988 (less than 2%). Nosocomial acquisition occurred in 74.8% of isolates. All age groups were affected, but 45.9% of patients were in the 'extremes of age' group (younger than one or older than 60 years of age). The prevalence was highest in the medical ward (27%), followed by the paediatrics combined medical and surgical ward (20.7%), the outpatient department (18%), the adult surgical ward (17.1%) and the intensive care units (17.1%). Two-thirds (66.7%) of cases represented infection and the remainder represented colonization. Surgical wounds (31.1%), the chest (27%) and endovascular catheters (20.3%) were the most common sites of infection. Bacteremia occurred in 27% of patients. Local signs (68.9%) and fever (60.8%) were the most common clinical manifestations. Respiratory distress and septic shock occurred in 28.4% and 6.8% of cases, respectively. Of 74 patients with MRSA infection and 37 patients with MRSA colonization, 91.9% and 56.8% received antibiotics in the preceding six weeks, respectively (P<0.0001). The total mortality of patients with MRSA infection was 60.8%; 37.8% of deaths were the result of MRSA infection and 23% were the result of other diseases.
CONCLUSIONS: The prevalence of MRSA is high and rapidly increasing at King Abdulaziz University Hospital, as it is worldwide. Control measures to prevent the spread of MRSA in hospitals should continue with reinforcement of hygienic precautions and development of policies to restrict the use of antibiotics.

Entities:  

Keywords:  Colonization; Infection; MRSA; Saudi Arabia; Staphylococcus aureus

Year:  2002        PMID: 18159397      PMCID: PMC2094880          DOI: 10.1155/2002/235213

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  41 in total

1.  Assigning responsibility: using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus.

Authors:  M D Nettleman; A Trilla; M Fredrickson; M Pfaller
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

2.  Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence.

Authors:  G L French; A F Cheng; J M Ling; P Mo; S Donnan
Journal:  J Hosp Infect       Date:  1990-02       Impact factor: 3.926

3.  Staphylococcus aureus infections.

Authors:  S Blot; K Vandewoude; F Colardyn
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

4.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

5.  An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies.

Authors:  K Crossley; D Loesch; B Landesman; K Mead; M Chern; R Strate
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

6.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

7.  Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.

Authors:  D P Levine; R D Cushing; J Jui; W J Brown
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

8.  Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  R L Thompson; I Cabezudo; R P Wenzel
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

9.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Authors:  A L Panlilio; D H Culver; R P Gaynes; S Banerjee; T S Henderson; J S Tolson; W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

Review 10.  Methicillin-resistant Staphylococcus aureus in extended-care facilities: experiences in a Veterans' Affairs nursing home and a review of the literature.

Authors:  L J Strausbaugh; C Jacobson; D L Sewell; S Potter; T T Ward
Journal:  Infect Control Hosp Epidemiol       Date:  1991-01       Impact factor: 3.254

View more
  10 in total

1.  Prevalence of Bacterial Pathogens in Aseer Region, Kingdom of Saudi Arabia: Emphasis on Antimicrobial Susceptibility of Staphylococcus aureus.

Authors:  Mohamed E Hamid; Faisal Y Mustafa; Ali Alwaily; Safa Abdelrahman; Tarig Al Azragi
Journal:  Oman Med J       Date:  2011-09

2.  Blockade of gC1qR/p33, a receptor for C1q, inhibits adherence of Staphylococcus aureus to the microvascular endothelium.

Authors:  Shneh Sethi; Mathias Herrmann; Jonas Roller; Lutz von Müller; Ellinor I Peerschke; Berhane Ghebrehiwet; Irma Bajric; Michael D Menger; Matthias W Laschke
Journal:  Microvasc Res       Date:  2011-04-22       Impact factor: 3.514

3.  Healthcare costs of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa infections in veterans: role of vitamin D deficiency.

Authors:  D Youssef; B Bailey; A El-Abbassi; M Vannoy; T Manning; J P Moorman; A N Peiris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-22       Impact factor: 3.267

4.  Susceptibilities of common bacterial isolates from oman to old and new antibiotics.

Authors:  Mubarak Al-Yaqoubi; Kamal Elhag
Journal:  Oman Med J       Date:  2008-07

5.  Eleven-Year surveillance of methicillin-resistant Staphylococcus aureus infections at an Academic Health Centre.

Authors:  Safiya Al Musawi; Qassim Alkhaleefa; Samia Alnassri; Aisha M Alamri; Amani Alnimr
Journal:  J Prev Med Hyg       Date:  2022-04-26

Review 6.  Novel anti-infective compounds from marine bacteria.

Authors:  Hafizur Rahman; Brian Austin; Wilfrid J Mitchell; Peter C Morris; Derek J Jamieson; David R Adams; Andrew Mearns Spragg; Michael Schweizer
Journal:  Mar Drugs       Date:  2010-03-05       Impact factor: 5.118

7.  Frequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitals.

Authors:  Atif H Asghar
Journal:  Ann Saudi Med       Date:  2011 Sep-Oct       Impact factor: 1.526

8.  Prevalence and factors associated with wound colonization by Staphylococcus spp. and Staphylococcus aureus in hospitalized patients in inland northeastern Brazil: a cross-sectional study.

Authors:  Gilmara Celli Maia Almeida; Marquiony Marques dos Santos; Nara Grazieli Martins Lima; Thiago André Cidral; Maria Celeste Nunes Melo; Kenio Costa Lima
Journal:  BMC Infect Dis       Date:  2014-06-13       Impact factor: 3.090

9.  Methicillin-resistant Staphylococcus aureus development in intensive care patients. A case-control study.

Authors:  Mohamed A Ali; Ahmad M Rajab; Abdullah M Al-Khani; Saleh Q Ayash; Amjad Chams Basha; Ahmed Abdelgadir; Tawfik M Rajab; Saed Enabi; Nazmus Saquib
Journal:  Saudi Med J       Date:  2020-11       Impact factor: 1.484

10.  Characteristics and risk factors of hospital acquired - Methicillin-resistant Staphylococcus aureus (HA-MRSA) infection of pediatric patients in a tertiary care hospital in Riyadh, Saudi Arabia.

Authors:  Khalid Alrabiah; Sulaiman Al Alola; Esam Al Banyan; Mohammad Al Shaalan; Sameera Al Johani
Journal:  Int J Pediatr Adolesc Med       Date:  2016-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.